The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | 2020 UK AML trials update
Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, University of Birmingham, Birmingham, UK, discusses the research underway through the UK IMPACT stem cell transplantation cooperative, including the PRO-DLI trial (NCT02856464), investigating whether prophylactic donor lymphocyte infusions (DLI) delivered as part of a planned schedule improves disease-free survival in patients with myeloid malignancies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
